--- title: "Kisspeptin-10: Benefits, Dosage & Side Effects" description: "Kisspeptin-10 explained: how this brain peptide drives LH, FSH and testosterone, what human studies show, side effects, WADA status and its 2026 FDA status." canonical: "https://www.vitalsvault.com/peptides/kisspeptin-10" last-updated: 2026-08-22 --- # Kisspeptin-10: Benefits, Dosage & Side Effects > Kisspeptin-10 explained: how this brain peptide drives LH, FSH and testosterone, what human studies show, side effects, WADA status and its 2026 FDA status. ![A Jordanian man, 36, round glasses, short curly black beard, and a white woman, 34, copper-red hair, freckles, sit close on a park bench sharing a…](https://www.vitalsvault.com/_next/image?url=%2Fpublic-v3%2Fshoot%2Fpeptides%2Fpep-kisspeptin.webp&w=3840&q=75&dpl=shadow-production-f0162cb4d465-40992538108-1) Peptide Guide · Sexual and reproductive health # Kisspeptin-10 KP-10 Kisspeptin was first found as a cancer gene in Hershey, Pennsylvania. Seven years later it turned out to be the switch that starts puberty, and kisspeptin-10 is the short fragment researchers use to flip it. [Get early access to peptide care](https://www.vitalsvault.com/peptides-waitlist)[Start with 120+ lab tests · $99](https://www.vitalsvault.com/labs#plans) Free to join · One email when peptide care opens · Most lab results in 3–5 business days Studied forReproductive hormone release, fertility and hypothalamic disorders EvidenceEarly human data Taken asAs prescribed by a clinician Studied forReproductive hormone release, fertility and hypothalamic disorders EvidenceEarly human data Taken asAs prescribed by a clinician ## Kisspeptin-10, in short Kisspeptin-10 is the shortest fully active piece of kisspeptin, the brain hormone that switches on GnRH neurons and so sets off LH, FSH and sex hormone release. In small human studies it raised LH and testosterone in healthy men and in men with type 2 diabetes and low testosterone. It is studied for fertility and reproductive hormone disorders, with early human evidence. Medically reviewed by [Robert Lufkin, MD (opens in a new tab)](https://www.robertlufkinmd.com/) Chief Medical Officer, Vitals Vault · Updated October 29, 2026 · 19 sources ## At a glance Early human data TypePeptide of 10 amino acids, the minimal kisspeptin sequence with full activity[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011) Made byKisspeptin neurons in the hypothalamus[8](https://www.vitalsvault.com/peptides/kisspeptin-10#source-koysombat-2025) ReceptorKISS1R (also called GPR54)[5](https://www.vitalsvault.com/peptides/kisspeptin-10#source-seminara-2003)[6](https://www.vitalsvault.com/peptides/kisspeptin-10#source-derouxs-2003) Studied forLH, FSH and testosterone release, fertility treatment, hypothalamic disorders[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011)[7](https://www.vitalsvault.com/peptides/kisspeptin-10#source-abbara-2021) EvidenceSmall human studies of kisspeptin-10 in men; related kisspeptin-54 studies in women with hypothalamic amenorrhea[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011)[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026)[4](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2010) FDA statusNot approved. On FDA’s compounding safety page. Not covered by the October 2026 policy[18](https://www.vitalsvault.com/peptides/kisspeptin-10#source-fda-bulks)[17](https://www.vitalsvault.com/peptides/kisspeptin-10#source-ncpa) SportProhibited by WADA in males (kisspeptin and its agonists)[19](https://www.vitalsvault.com/peptides/kisspeptin-10#source-wada-2026) ## Before you consider Kisspeptin-10 - Safety Short human studies reported few problems, but they were small and brief. Long-term safety is unknown, and FDA cites immune-reaction and impurity concerns.[4](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2010)[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026)[18](https://www.vitalsvault.com/peptides/kisspeptin-10#source-fda-bulks) [Side effects and safety](https://www.vitalsvault.com/peptides/kisspeptin-10#safety) - Legal status Not FDA approved. FDA put it in category 2 of nominated bulk substances in 2023, and it is not among the six peptides covered by the October 29, 2026 enforcement discretion.[18](https://www.vitalsvault.com/peptides/kisspeptin-10#source-fda-bulks)[17](https://www.vitalsvault.com/peptides/kisspeptin-10#source-ncpa) [FDA status](https://www.vitalsvault.com/peptides/kisspeptin-10#fda-status) - How it’s taken In studies it was given as a timed infusion or injection, into a vein or under the skin. There is no approved product.[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011)[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026) [Forms and dosage](https://www.vitalsvault.com/peptides/kisspeptin-10#how-taken) ## How does Kisspeptin-10 work? It works high up in the brain, where the signal that starts the reproductive hormones begins. - ### Starts the signal It switches on the brain cells that release the hormone that starts the reproductive chain.[7](https://www.vitalsvault.com/peptides/kisspeptin-10#source-abbara-2021)[8](https://www.vitalsvault.com/peptides/kisspeptin-10#source-koysombat-2025) - ### Raises sex hormones In healthy men, it raised a pituitary hormone within minutes, and a longer infusion also raised testosterone.[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011) - ### Needs a rhythm Constant exposure blunts the response. On-and-off exposure keeps it, like the body’s own pulses.[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026)[4](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2010) ## Kisspeptin-10 benefits: what it is studied for The evidence is early but human. Studies measured hormone responses in small groups, and none tests kisspeptin-10 for pregnancy or symptom relief. The IVF card used the longer form, kisspeptin-54. 1. Human study01 ### LH and testosterone in men Kisspeptin-10 given to healthy men raised LH in a dose-dependent way, and a 22.5-hour infusion raised testosterone from 16.6 to 24.0 nmol/L.[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011) 2. Human study02 ### Sustained signal for 12 days In a 2026 placebo-controlled study, intermittent kisspeptin-10 infusions under the skin kept gonadotropins raised across 12 days in seven healthy men.[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026) 3. Human study03 ### Egg maturation in IVF In 53 women having IVF, one injection of kisspeptin-54 triggered egg maturation, and 23% had a clinical pregnancy. There was no comparison group.[14](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2014) ## What the research shows Early human data 1. 1 · Cells in a labNot cited This guide cites no findings at this level. Shows a mechanism 2. 2 · Animals Studied Mice without the kisspeptin receptor also fail to go through puberty. This shows the system matters, but it is not a test of kisspeptin-10.[5](https://www.vitalsvault.com/peptides/kisspeptin-10#source-seminara-2003)[6](https://www.vitalsvault.com/peptides/kisspeptin-10#source-derouxs-2003) Shows an effect in a body 3. 3 · People Studied Kisspeptin-10 raised hormones in small groups of healthy men, including for 12 days with on-and-off infusions. No trial shows pregnancy or symptom relief from it.[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011)[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026) Shows it works in people Kisspeptin has real human reproductive-endocrinology research behind it, with most studies using infusions in small groups of healthy men or in women with hypothalamic amenorrhea. A 2026 review of kisspeptin approaches for testosterone-therapy suppression found direct evidence for restoring fertility remains limited.[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011)[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026)[4](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2010)[9](https://www.vitalsvault.com/peptides/kisspeptin-10#source-cretu-2026) The full guide to Kisspeptin-10 9 min read · Medically reviewed by Robert Lufkin, MD ## A cancer gene from Hershey that turned out to run puberty In 1996, cancer researchers at Penn State’s College of Medicine in Hershey, Pennsylvania, a town better known for its chocolate kisses, were hunting for genes that stop melanoma from spreading. They found one, named it KiSS-1, and showed that putting it back into melanoma cells suppressed their ability to metastasize. In healthy tissue, its highest expression was in the placenta, an odd address for a cancer gene. For a few years, nobody knew what its protein did in a healthy body. In 2001, a team in England cloned a human brain receptor closely related to a rat orphan receptor called GPR54 and found that peptides made from KiSS-1 activated it potently. The receptor’s gene was most highly expressed in the brain, the pituitary and the placenta. Then, in 2003, two groups reached the same answer from opposite directions. In France, researchers studying a large family in which five siblings never went through puberty found that all five carried a deletion in the GPR54 gene. In Boston, a second team found GPR54 mutations in other patients with absent puberty and bred mice lacking the receptor, which had small testes or immature ovaries. The finding reshaped reproductive endocrinology. Kisspeptin and its receptor, now called KISS1R, are essential for normal GnRH release and for puberty itself. A peptide first studied for stopping cancer spread turned out to sit at the top of the reproductive hormone chain.[10](https://www.vitalsvault.com/peptides/kisspeptin-10#source-lee-1996)[11](https://www.vitalsvault.com/peptides/kisspeptin-10#source-muir-2001)[6](https://www.vitalsvault.com/peptides/kisspeptin-10#source-derouxs-2003)[5](https://www.vitalsvault.com/peptides/kisspeptin-10#source-seminara-2003)[7](https://www.vitalsvault.com/peptides/kisspeptin-10#source-abbara-2021) ## How kisspeptin works: the switch above the switch Reproduction runs on a relay. The hypothalamus releases GnRH in pulses, the pituitary answers with LH and FSH, and those two hormones tell the testes or ovaries to make testosterone or estradiol and to mature sperm or eggs. Kisspeptin sits one step above GnRH. Kisspeptin neurons in the hypothalamus, many of which also make a partner signal called neurokinin B, set the pace of those GnRH pulses. The 2003 mouse work showed how specific that job is. Mice without the receptor still had normal amounts of GnRH stored in the hypothalamus, and they still responded when GnRH or gonadotropins were given. The machinery downstream, pituitary and gonads, worked. What was missing was the signal to start it. Kisspeptin comes in several lengths. Kisspeptin-54 is the major form circulating in human blood, and kisspeptin-10 is the minimal sequence that keeps full activity at the receptor. In men, kisspeptin-54 has a half-life in blood of about 28 minutes, and human studies have used both single injections and infusions. Reviews also describe kisspeptin acting on sexual behavior and attraction, the placenta and bone. Its neighbor, neurokinin B, drives menopausal hot flashes, and a drug that blocks its receptor, fezolinetant, is now approved for them. That approval shows how ready this small corner of the brain has become for medicine.[8](https://www.vitalsvault.com/peptides/kisspeptin-10#source-koysombat-2025)[7](https://www.vitalsvault.com/peptides/kisspeptin-10#source-abbara-2021)[5](https://www.vitalsvault.com/peptides/kisspeptin-10#source-seminara-2003)[14](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2014)[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011)[3](https://www.vitalsvault.com/peptides/kisspeptin-10#source-dhillo-2005) ## Kisspeptin-10 and testosterone in men The first study of kisspeptin-10 in people came from Edinburgh in 2011. Given as a single injection into a vein, it caused a rapid, dose-dependent rise in LH in healthy men, roughly tripling it within 30 minutes at the most effective dose. A higher dose produced a smaller response, an early hint that more is not always better with this signal. Longer infusions showed what happens downstream. Over 22.5 hours, LH rose about fourfold and testosterone climbed from 16.6 to 24.0 nmol/L. A gentler infusion revealed the mechanism more clearly, raising LH pulse frequency from 0.7 to 1.0 pulses an hour and making each burst larger. That is consistent with kisspeptin-10 speeding up the body’s own GnRH rhythm, which cannot be measured directly in people. A London group had already shown the same direction with the longer kisspeptin-54. In a 2005 double-blind crossover study of 6 men, a 90-minute infusion raised LH, FSH and testosterone compared with saline. The practical question is whether the effect lasts. A 2026 Imperial College study of 15 healthy men, split across three experiments, gave kisspeptin-10 under the skin. In four men, five days of continuous infusion left LH and FSH no higher than placebo, although testosterone stayed raised. In seven others, intermittent infusions, running for part of each day, kept gonadotropins up across 12 days, and the receptor still responded at the end.[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011)[3](https://www.vitalsvault.com/peptides/kisspeptin-10#source-dhillo-2005)[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026) ## When low testosterone is a message problem Low testosterone is common in men with type 2 diabetes and severe obesity, and it is tempting to assume the testes have simply worn out. In 2010, the Edinburgh team proposed another explanation. Evidence pointed to the hypothalamus releasing less GnRH in these men, and they hypothesized that falling kisspeptin is the common pathway linking high blood sugar, inflammation, leptin and estrogen feedback to low testosterone. In 2013 they tested the idea in a proof-of-concept study. Five men with type 2 diabetes and low testosterone, with an average BMI of about 40, were given kisspeptin-10. Their LH rose about as much as it did in seven healthy men. During an 11-hour infusion in four of them, LH pulse frequency increased and testosterone rose from 8.5 to 11.4 nmol/L. In these five men, the pituitary and testes could still answer when called. That is consistent with a quiet signal upstream, though it does not prove missing kisspeptin is the cause. Picture a factory with a working production line and a phone that has stopped ringing. One way to read it is that some metabolic low testosterone is a message problem, and it explains why weight, blood sugar and inflammation keep turning up in a hormone story. This is still a hypothesis built on very small studies, and it does not make kisspeptin a therapy for diabetes-related low testosterone. It does suggest two practical habits. Measure LH alongside testosterone, and count metabolic health as part of the hormone conversation instead of a separate topic.[12](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2010)[13](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2013) ## Kisspeptin for women: cycles and IVF Hypothalamic amenorrhea is the loss of periods because the brain stops sending its signal, while the ovaries remain healthy. In 2010, a London team gave kisspeptin-54 to women with the condition. Frequent injections lost their effect quickly, with the FSH response nearly gone by the second day. Spacing made the difference. A less frequent schedule caused only partial desensitization, and after 8 weeks those women had significantly higher reproductive hormones than women given saline. No adverse effects were seen. The lesson runs through all kisspeptin work. The axis listens to rhythm, and constant exposure tunes it out. The most clinical use so far is in IVF. In 2014, 53 women undergoing IVF received a single injection of kisspeptin-54 to trigger the final maturation of their eggs. Embryos were transferred in 92 percent, and 23 percent had a clinical pregnancy. Because kisspeptin works through the body’s own GnRH, reviewers describe it as a potentially safer, more physiological trigger for this step. These studies used kisspeptin-54, the longer form. Their results are a guide to what the kisspeptin system can do, and they should not be assumed to transfer automatically to kisspeptin-10.[4](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2010)[14](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2014)[8](https://www.vitalsvault.com/peptides/kisspeptin-10#source-koysombat-2025) ## Kisspeptin and sexual desire: what brain scans show Kisspeptin’s reach goes beyond hormone levels. In a 2022 trial at Imperial College London, 32 premenopausal women with hypoactive sexual desire disorder received a 75-minute infusion of kisspeptin-54 on one day and placebo on another, while their brains were scanned as they watched erotic videos and looked at faces. Kisspeptin shifted activity in regions tied to sexual and attraction processing. Some of those changes tracked with how the women felt. Kisspeptin’s boost to hippocampal activity during erotic videos was larger in women with more baseline distress about their sexual function, and its effect in a region called the posterior cingulate cortex correlated with lower sexual aversion. It was well tolerated, with no reported adverse effects. A matching 2023 trial in 32 men with low desire found kisspeptin modulated the brain’s sexual-processing network, increased penile tumescence during sexual videos by up to 56 percent more than placebo, and raised happiness about sex. The authors suggested kisspeptin could become the first drug for low desire in men. These were single infusions in a scanner, and brain signals are a long way from months of daily life. They do suggest that the hormone at the top of the reproductive chain also speaks to the parts of the brain that decide whether sex feels appealing.[15](https://www.vitalsvault.com/peptides/kisspeptin-10#source-thurston-2022)[16](https://www.vitalsvault.com/peptides/kisspeptin-10#source-mills-2023) Know your baseline before any peptide 120+ lab tests at Quest Diagnostics, every result reviewed by a licensed clinician. Most results in 3–5 business days. A baseline today gives your clinician something to compare against if you start Kisspeptin-10 later. [Start with 120+ lab tests · $99](https://www.vitalsvault.com/labs#plans)[Get early access to peptide care](https://www.vitalsvault.com/peptides-waitlist) Full refund before your blood draw · No membership ## What we actually know in people Lay the human record side by side and it is a set of careful, small physiology studies. Most enrolled between 5 and 53 people, ran for hours to weeks, and measured hormones or brain signals. Together they show that kisspeptin can drive the human reproductive axis on demand. They do not yet show better fertility, better sex lives or symptom relief from kisspeptin-10 itself. The question many men bring to kisspeptin is whether it can protect fertility on testosterone therapy, which suppresses LH, FSH and sperm production. A 2026 narrative review of peptide strategies for that problem found that kisspeptin approaches may support the body’s own hormone signaling, but that direct evidence of restored sperm production or fertility after testosterone suppression remains limited. Much of the human work also comes from a small number of research groups, mainly in London and Edinburgh. That gives the field consistent methods, and it is also a reason to want independent replication before any of these findings are taken as settled.[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011)[13](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2013)[14](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2014)[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026)[9](https://www.vitalsvault.com/peptides/kisspeptin-10#source-cretu-2026) ## Kisspeptin-10 side effects and safety In short human studies, kisspeptin has been well tolerated. The 8-week kisspeptin-54 study in women observed no adverse effects, and the brain imaging trial in women reported none. The 2026 kisspeptin-10 study in men ran for 12 days. None of these tells us what happens over months or years. The main known limit is tolerance. Constant or too-frequent exposure blunts the response. Frequent kisspeptin-54 injections produced complete tolerance in women, and five days of continuous kisspeptin-10 left gonadotropins no higher than placebo in men. A poorly designed schedule can leave it doing nothing for LH and FSH. Product quality is the other issue. FDA has said compounded kisspeptin-10 may pose a risk of immunogenicity, meaning the immune system could react to it, and may contain peptide-related impurities that are hard to characterize. It also notes no, or only limited, safety information for the proposed routes. Because kisspeptin raises sex hormones, people with hormone-sensitive cancers, anyone pregnant or trying to conceive, and anyone already on testosterone or another hormonal medicine should talk with a clinician first.[4](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2010)[15](https://www.vitalsvault.com/peptides/kisspeptin-10#source-thurston-2022)[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026)[18](https://www.vitalsvault.com/peptides/kisspeptin-10#source-fda-bulks) ## The four labs that show where the chain is weak Kisspeptin research is really a study of a relay, and four blood tests show which runner has slowed. LH is the pituitary’s message to the gonads. In men, a low or normal LH alongside low testosterone points up the chain, toward the hypothalamus or pituitary. A high LH with low testosterone points down, toward the testes. FSH is LH’s partner, driving sperm production in men and follicle growth in women. Total testosterone is the main output of the axis in men. Estradiol tracks the ovarian cycle in women and, in men, estrogen made mostly from androgens, which also feeds back on the brain. Measured together and repeated, these four turn a vague complaint into a map. That is how Vitals Vault approaches hormone questions. A blood panel at Quest Diagnostics comes first, a licensed clinician reads it alongside your history, and a retest shows which way the numbers are moving.[8](https://www.vitalsvault.com/peptides/kisspeptin-10#source-koysombat-2025)[13](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2013) ## Where kisspeptin-10 stands in 2026 Kisspeptin-10 is not FDA-approved for any use. On September 29, 2023, FDA placed it in category 2 of bulk substances nominated for 503A compounding, citing immunogenicity risk, impurity concerns and limited safety information. It was not among the six peptides covered by FDA’s October 29, 2026 enforcement discretion, so that policy does not open a compounding route for it. Sport has its own rule. The World Anti-Doping Agency’s 2026 Prohibited List names kisspeptin and its agonists under S2.2.1, testosterone-stimulating peptides prohibited in males, in and out of competition.[18](https://www.vitalsvault.com/peptides/kisspeptin-10#source-fda-bulks)[17](https://www.vitalsvault.com/peptides/kisspeptin-10#source-ncpa)[19](https://www.vitalsvault.com/peptides/kisspeptin-10#source-wada-2026) ## What this means for you Kisspeptin is the signal at the very top of the reproductive chain, found in a hunt for melanoma genes and confirmed by families whose puberty never started. Kisspeptin-10, its shortest active piece, reliably raises LH and testosterone in men in small studies, and related work with the longer form points to roles in fertility treatment and in how the brain handles desire. If low testosterone or irregular cycles are your question, the useful first step is to find out where the chain has gone quiet. LH and FSH read next to properly timed testosterone or estradiol, and your history, help a clinician tell whether the message or the gland looks like the problem, sometimes with more testing to settle it.[5](https://www.vitalsvault.com/peptides/kisspeptin-10#source-seminara-2003)[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011)[8](https://www.vitalsvault.com/peptides/kisspeptin-10#source-koysombat-2025) Know your baseline before any peptide 120+ lab tests at Quest Diagnostics, every result reviewed by a licensed clinician. Most results in 3–5 business days. A baseline today gives your clinician something to compare against if you start Kisspeptin-10 later. [Start with 120+ lab tests · $99](https://www.vitalsvault.com/labs#plans)[Get early access to peptide care](https://www.vitalsvault.com/peptides-waitlist) Full refund before your blood draw · No membership ## What to expect with Kisspeptin-10 In studies, the hormone response came fast. LH rose within about 30 minutes of an intravenous dose of kisspeptin-10, and testosterone rose over hours of infusion. Timing then decided everything, since continuous exposure faded within days while intermittent exposure held up over 12 days. There is no approved product, so any clinical use would sit within research or close specialist care. The sensible frame is a measured one, with baseline LH, FSH and testosterone or estradiol first and repeat testing to see whether the chain is responding.[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011)[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026) ## Key Kisspeptin-10 studies - Lee et al., 1996[10](https://www.vitalsvault.com/peptides/kisspeptin-10#source-lee-1996) Laboratory gene discovery · Human melanoma cells KiSS-1 identified as a gene that suppresses melanoma spread Limits: Cancer cells; reproductive role unknown at the time - Seminara et al. and de Roux et al., 2003[5](https://www.vitalsvault.com/peptides/kisspeptin-10#source-seminara-2003)[6](https://www.vitalsvault.com/peptides/kisspeptin-10#source-derouxs-2003) Family genetic studies plus mouse model · Families with absent puberty; receptor-deficient mice Loss of the kisspeptin receptor causes failure of puberty Limits: Rare genetic cases - Dhillo et al., 2005[3](https://www.vitalsvault.com/peptides/kisspeptin-10#source-dhillo-2005) Double-blind, placebo-controlled crossover · 6 healthy men Kisspeptin-54 infusion raised LH, FSH and testosterone Limits: Very small; single infusion; longer form - George et al., 2011[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011) Dose-response and infusion study · Healthy men Kisspeptin-10 raised LH within 30 minutes and raised testosterone and LH pulse frequency Limits: Small groups; hours, not weeks - George et al., 2013[13](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2013) Proof-of-concept study · 5 men with type 2 diabetes and low testosterone, 7 healthy men LH and testosterone rose; pulse frequency increased Limits: Tiny, short, no placebo arm in the infusion - Jayasena et al., 2010[4](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2010) Comparison of dosing patterns, then 8-week study · Women with hypothalamic amenorrhea Frequent injections caused complete tolerance; a less frequent schedule caused partial desensitization but kept hormones raised Limits: Kisspeptin-54; hormone outcomes only - Jayasena et al., 2014[14](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2014) Open dose-finding study · 53 women undergoing IVF One kisspeptin-54 injection triggered egg maturation; 23% clinical pregnancy Limits: No comparison group; longer form - Mills et al., 2023[16](https://www.vitalsvault.com/peptides/kisspeptin-10#source-mills-2023) Randomized, placebo-controlled crossover with brain imaging · 32 men with low sexual desire Changed sexual brain processing; more penile tumescence and happiness about sex Limits: Single infusion of kisspeptin-54 - Yeung et al., 2026[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026) Randomized, single-blinded, placebo-controlled · 15 healthy men across three experiments Intermittent kisspeptin-10 sustained gonadotropins for 12 days in seven men; continuous did not, though testosterone stayed raised Limits: Healthy men; short duration Key studies on Kisspeptin-10 | Study | Design | Who | What it found | Limits | | --- | --- | --- | --- | --- | | Lee et al., 1996[10](https://www.vitalsvault.com/peptides/kisspeptin-10#source-lee-1996) | Laboratory gene discovery | Human melanoma cells | KiSS-1 identified as a gene that suppresses melanoma spread | Cancer cells; reproductive role unknown at the time | | Seminara et al. and de Roux et al., 2003[5](https://www.vitalsvault.com/peptides/kisspeptin-10#source-seminara-2003)[6](https://www.vitalsvault.com/peptides/kisspeptin-10#source-derouxs-2003) | Family genetic studies plus mouse model | Families with absent puberty; receptor-deficient mice | Loss of the kisspeptin receptor causes failure of puberty | Rare genetic cases | | Dhillo et al., 2005[3](https://www.vitalsvault.com/peptides/kisspeptin-10#source-dhillo-2005) | Double-blind, placebo-controlled crossover | 6 healthy men | Kisspeptin-54 infusion raised LH, FSH and testosterone | Very small; single infusion; longer form | | George et al., 2011[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011) | Dose-response and infusion study | Healthy men | Kisspeptin-10 raised LH within 30 minutes and raised testosterone and LH pulse frequency | Small groups; hours, not weeks | | George et al., 2013[13](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2013) | Proof-of-concept study | 5 men with type 2 diabetes and low testosterone, 7 healthy men | LH and testosterone rose; pulse frequency increased | Tiny, short, no placebo arm in the infusion | | Jayasena et al., 2010[4](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2010) | Comparison of dosing patterns, then 8-week study | Women with hypothalamic amenorrhea | Frequent injections caused complete tolerance; a less frequent schedule caused partial desensitization but kept hormones raised | Kisspeptin-54; hormone outcomes only | | Jayasena et al., 2014[14](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2014) | Open dose-finding study | 53 women undergoing IVF | One kisspeptin-54 injection triggered egg maturation; 23% clinical pregnancy | No comparison group; longer form | | Mills et al., 2023[16](https://www.vitalsvault.com/peptides/kisspeptin-10#source-mills-2023) | Randomized, placebo-controlled crossover with brain imaging | 32 men with low sexual desire | Changed sexual brain processing; more penile tumescence and happiness about sex | Single infusion of kisspeptin-54 | | Yeung et al., 2026[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026) | Randomized, single-blinded, placebo-controlled | 15 healthy men across three experiments | Intermittent kisspeptin-10 sustained gonadotropins for 12 days in seven men; continuous did not, though testosterone stayed raised | Healthy men; short duration | ## Kisspeptin-10 myths and evidence - ### Kisspeptin is a testosterone booster you can take continuously Constant exposure backfires. Five days of continuous kisspeptin-10 left LH and FSH no higher than placebo in men, and frequent kisspeptin-54 caused complete tolerance in women. In the longer studies, intermittent patterns were what kept the gonadotropin response going.[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026)[4](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2010) - ### Kisspeptin works directly on the testes It works in the brain. Kisspeptin acts on KISS1R to trigger GnRH release, which then prompts LH and FSH from the pituitary. That chain, not a direct hit on the testes, is the main pathway the research describes.[7](https://www.vitalsvault.com/peptides/kisspeptin-10#source-abbara-2021)[8](https://www.vitalsvault.com/peptides/kisspeptin-10#source-koysombat-2025) - ### Kisspeptin-10 and kisspeptin-54 are the same thing They share the active end but differ in length. Kisspeptin-54 is the main circulating form in people, and most fertility and desire trials used it. Kisspeptin-10 is the minimal fully active fragment, studied mostly in men.[14](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2014)[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011) - ### Kisspeptin has been proven to boost libido Not yet. Trials in 2022 and 2023 found single infusions of kisspeptin-54 changed brain responses to sexual cues in people with low desire. Neither trial showed lasting improvements in sex lives.[15](https://www.vitalsvault.com/peptides/kisspeptin-10#source-thurston-2022)[16](https://www.vitalsvault.com/peptides/kisspeptin-10#source-mills-2023) Know your baseline first 120+ lab tests at Quest, every result reviewed by a licensed clinician. Most results in 3–5 business days. [Start with 120+ lab tests · $99](https://www.vitalsvault.com/labs#plans) ## How is Kisspeptin-10 taken? In studies, kisspeptin-10 was given by intravenous or subcutaneous infusion and by injection. There is no approved product. Human work has used carefully timed, intermittent delivery rather than constant exposure.[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011)[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026) ## Kisspeptin-10 dosage There is no FDA-approved dose of kisspeptin-10 for any use. Human studies gave it into a vein, or under the skin by pump, in research units: single weight-based injections or infusions lasting hours. A continuous five-day infusion under the skin lost its effect on LH and FSH, though testosterone stayed raised, while eight-hour daily infusions kept LH up for 12 days. These were research protocols, not a self-administered regimen. Your clinician sets any dose.[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011)[13](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2013)[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026) ## Typical Kisspeptin-10 dosage No kisspeptin-10 dose is approved. Studies in men gave single weight-based injections into a vein, or infusions into a vein or under the skin lasting hours, in research units with frequent blood sampling, and a continuous five-day infusion lost its effect on LH and FSH while testosterone stayed raised. These are research protocols, not a home regimen, and a clinician decides any use. These are reference doses from FDA labels, studies in people and clinical practice reports, shown for education. They are not a recommendation or a prescription. Your dose, form and schedule should be set by a licensed clinician who knows your history and lab results. Already have a prescribed dose? The [peptide dosage calculator](https://www.vitalsvault.com/peptides/tools/dosage-calculator) turns it into the units to draw on an insulin syringe. - Human trial · Injection into a vein 0.01 to 3.0 µg/kg tested; largest LH rise at 1 µg/kg Single dose[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011) Healthy men in a dose-finding study; 3 µg/kg gave a smaller response than 1 µg/kg. - Human trial · Infusion into a vein 1.5 to 4 µg/kg per hour Continuous, for up to 22.5 hours[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011) Healthy men; LH and testosterone rose. - Human trial · Injection, then infusion, into a vein 0.3 µg/kg single injection; 4 µg/kg per hour infusion Single dose; infusion over 11 hours on a separate day[13](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2013) Men with type 2 diabetes and low testosterone. - Human trial · Infusion under the skin by pump 150 nmol per hour 8 hours a day for 12 days[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026) Healthy men; the LH rise held. A continuous 5-day infusion at 180 nmol per hour lost its effect on LH and FSH. Typical Kisspeptin-10 doses in people, by source | Source | Form | Amount | How often | Notes | | --- | --- | --- | --- | --- | | Human trial[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011) | Injection into a vein | 0.01 to 3.0 µg/kg tested; largest LH rise at 1 µg/kg | Single dose | Healthy men in a dose-finding study; 3 µg/kg gave a smaller response than 1 µg/kg. | | Human trial[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011) | Infusion into a vein | 1.5 to 4 µg/kg per hour | Continuous, for up to 22.5 hours | Healthy men; LH and testosterone rose. | | Human trial[13](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2013) | Injection, then infusion, into a vein | 0.3 µg/kg single injection; 4 µg/kg per hour infusion | Single dose; infusion over 11 hours on a separate day | Men with type 2 diabetes and low testosterone. | | Human trial[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026) | Infusion under the skin by pump | 150 nmol per hour | 8 hours a day for 12 days | Healthy men; the LH rise held. A continuous 5-day infusion at 180 nmol per hour lost its effect on LH and FSH. | ## Is Kisspeptin-10 right for you? A clinician makes the call. These are the questions they will ask first. ### It may suit - Adults with unexplained low testosterone or irregular cycles who want to understand which part of the axis is involved - People who want to track LH, FSH, testosterone and estradiol over time ### Talk to a clinician first if you are - Hormone-sensitive cancers (prostate or breast) - Planning pregnancy, pregnant or breastfeeding - Tested athletes (WADA prohibits kisspeptin and its analogues in males) - Taking testosterone, clomiphene or other hormonal medicine - A pituitary or hypothalamic condition Vitals Vault peptide care starts with a blood panel and a licensed clinician, and ends with a retest. [Get early access to peptide care](https://www.vitalsvault.com/peptides-waitlist) ## Reproductive hormones are a signal chain, and kisspeptin is the first link Low testosterone or missed periods can come from a failure at any link in the chain from brain to gonads. Hypothalamic amenorrhea shows the chain can go quiet from the top even when the ovaries are healthy. So the first step is to ask which link has failed. Labs separate them: low LH and FSH with low testosterone points high in the chain, while high LH and FSH points to the gonads.[8](https://www.vitalsvault.com/peptides/kisspeptin-10#source-koysombat-2025)[7](https://www.vitalsvault.com/peptides/kisspeptin-10#source-abbara-2021)[4](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2010)[9](https://www.vitalsvault.com/peptides/kisspeptin-10#source-cretu-2026) ### What else moves the same system 1. 01Find which link failedLow LH and FSH with low testosterone points high in the chain. High LH and FSH points to the gonads. 2. 02Tell your clinician what you takeTestosterone, clomiphene and other hormonal medicines change this axis. 3. 03Measure the chainLH, FSH, total testosterone and estradiol show which link is under-performing. 4. 04Retest over timeRepeat testing shows whether the chain is responding. ## Labs to check with Kisspeptin-10 A blood test before you start and a retest after shows what actually changed for you. It is how Vitals Vault approaches every treatment. 1. TestA baseline panel at Quest Diagnostics. 2. DecideA licensed clinician reviews your history and results. 3. RetestThe same markers again, side by side. [Start with 120+ lab tests · $99](https://www.vitalsvault.com/labs#plans) - [LHThe pituitary signal kisspeptin ultimately drives. Low or normal with low testosterone points high in the axis.](https://www.vitalsvault.com/biomarkers/lh) - [FSHPairs with LH to show whether the pituitary and gonads are responding.](https://www.vitalsvault.com/biomarkers/fsh) - [Total testosteroneThe main downstream result of the axis in men.](https://www.vitalsvault.com/biomarkers/testosterone-total) - [EstradiolTracks the ovarian axis in women; in men it is made mostly from androgens and feeds back on the brain.](https://www.vitalsvault.com/biomarkers/estradiol) ## Is Kisspeptin-10 FDA approved? No. Kisspeptin-10 is not FDA-approved for any use. FDA placed it in category 2 of nominated bulk substances for 503A compounding on September 29, 2023, citing immunogenicity risk, impurity concerns and limited safety information. It was not among the six peptides covered by FDA’s October 29, 2026 enforcement discretion.[18](https://www.vitalsvault.com/peptides/kisspeptin-10#source-fda-bulks)[17](https://www.vitalsvault.com/peptides/kisspeptin-10#source-ncpa) ### Kisspeptin-10 timeline 1. 2003 Two groups link loss-of-function mutations in the kisspeptin receptor gene GPR54 to hypogonadotropic hypogonadism.[5](https://www.vitalsvault.com/peptides/kisspeptin-10#source-seminara-2003)[6](https://www.vitalsvault.com/peptides/kisspeptin-10#source-derouxs-2003) 2. 2005 Kisspeptin-54 infusion raises LH, FSH and testosterone in healthy men.[3](https://www.vitalsvault.com/peptides/kisspeptin-10#source-dhillo-2005) 3. 2010 Intermittent kisspeptin-54 over 8 weeks stimulates reproductive hormones in women with hypothalamic amenorrhea.[4](https://www.vitalsvault.com/peptides/kisspeptin-10#source-jayasena-2010) 4. 2011 First study of kisspeptin-10 in people shows a rapid, dose-dependent LH rise in men.[1](https://www.vitalsvault.com/peptides/kisspeptin-10#source-george-2011) 5. September 29, 2023 FDA places kisspeptin-10 in category 2 of nominated bulk substances for 503A compounding.[18](https://www.vitalsvault.com/peptides/kisspeptin-10#source-fda-bulks) 6. 2026 Chronic subcutaneous kisspeptin-10 sustains gonadotropin release for 12 days in healthy men.[2](https://www.vitalsvault.com/peptides/kisspeptin-10#source-yeung-2026) ![A Samoan man, 38, slim, long black hair tied back, clean shaven sits on a beach log](https://www.vitalsvault.com/_next/image?url=%2Fpublic-v3%2Fshoot%2Fpeptides%2Ffaq-kisspeptin10.webp&w=3840&q=75&dpl=shadow-production-f0162cb4d465-40992538108-1) ## Kisspeptin-10 questions What is kisspeptin-10? Kisspeptin-10 is the minimal, fully active fragment of kisspeptin, a hypothalamic hormone that triggers GnRH release and so starts the reproductive hormone chain. It is not FDA-approved. What is kisspeptin used for? In research it is used to study puberty, fertility and hypothalamic disorders, and as a possible trigger for egg maturation in IVF. People ask about it for testosterone and libido. It is not FDA-approved to treat any condition. What are the benefits of kisspeptin-10? Studies show kisspeptin-10 raises LH, FSH and testosterone in healthy men. Clinical outcomes such as improved fertility or sexual function have not been shown for kisspeptin-10 itself. How does kisspeptin work? It binds the KISS1R receptor on GnRH neurons, which release GnRH. GnRH makes the pituitary release LH and FSH, and those hormones drive the testes or ovaries. What are the side effects of kisspeptin-10? Short-term studies report few adverse events, but they are small and brief. FDA notes immunogenicity and impurity concerns and limited safety information. What is the kisspeptin dosage? There is no FDA-approved dose. Research gave kisspeptin-10 into a vein or by pump under the skin, as single injections or timed infusions. With constant five-day exposure, LH and FSH fell back to placebo levels while testosterone stayed raised. Do not use an online chart to dose yourself; a clinician decides any use. Kisspeptin vs gonadorelin, what is the difference? Kisspeptin acts upstream and makes the body release its own GnRH. Gonadorelin is GnRH itself and acts directly on the pituitary. Both are named on WADA’s list for males. Is kisspeptin-10 FDA approved or legal? It is not FDA-approved. FDA lists it in category 2 for 503A compounding, with safety concerns, and it was not covered by the October 2026 enforcement discretion for six peptides. Products sold as research chemicals are not made or tested for people. Is kisspeptin banned in sports? In males, yes. WADA’s 2026 Prohibited List names kisspeptin and its agonist analogues among testosterone-stimulating peptides, prohibited in and out of competition. Can I get kisspeptin through Vitals Vault? No. Kisspeptin-10 is not an approved or compounding-eligible medicine. Vitals Vault is opening clinician-led peptide care that starts with a blood test, and you can join the peptides waitlist to hear first. ## Peptides, prescribed and measured Vitals Vault is opening peptide care that starts with your blood work, is prescribed by licensed US clinicians and ends with a retest. Join the waitlist to hear first. - Prescription only - Licensed US clinicians - Quest Diagnostics labs [Get early access to peptide care](https://www.vitalsvault.com/peptides-waitlist)[Start with 120+ lab tests · $99](https://www.vitalsvault.com/labs#plans) ## Keep reading [Full Peptide Guide](https://www.vitalsvault.com/peptides) - GonadorelinSynthetic GnRH, the hypothalamic signal that tells the pituitary to release LH and FSH. - PT-141Bremelanotide, an FDA-approved melanocortin peptide for low sexual desire in premenopausal women, sold as Vyleesi. - TesamorelinAn FDA-approved growth hormone releasing factor analog (Egrifta) for excess abdominal fat in adults with HIV-associated lipodystrophy. - FDA peptide update 2026What FDA’s October 2026 decision on six peptides means for you. ## Sources 1. 1. [George JT, et al. Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J Clin Endocrinol Metab. 2011 (opens in a new tab)](https://pubmed.ncbi.nlm.nih.gov/21632807/) 2. 2. [Yeung AC, et al. Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men. Eur J Endocrinol. 2026 (opens in a new tab)](https://pubmed.ncbi.nlm.nih.gov/42549827/) 3. 3. [Dhillo WS, et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab. 2005 (opens in a new tab)](https://pubmed.ncbi.nlm.nih.gov/16174713/) 4. 4. [Jayasena CN, et al. Twice-weekly administration of kisspeptin-54 for 8 weeks stimulates release of reproductive hormones in women with hypothalamic amenorrhea. Clin Pharmacol Ther. 2010 (opens in a new tab)](https://pubmed.ncbi.nlm.nih.gov/20980998/) 5. 5. [Seminara SB, et al. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003 (opens in a new tab)](https://pubmed.ncbi.nlm.nih.gov/14573733/) 6. 6. [de Roux N, et al. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A. 2003 (opens in a new tab)](https://pubmed.ncbi.nlm.nih.gov/12944565/) 7. 7. [Abbara A, et al. Clinical potential of kisspeptin in reproductive health. Trends Mol Med. 2021 (opens in a new tab)](https://pubmed.ncbi.nlm.nih.gov/34210598/) 8. 8. [Koysombat K, et al. Kisspeptin and neurokinin B: roles in reproductive health. Physiol Rev. 2025 (opens in a new tab)](https://pubmed.ncbi.nlm.nih.gov/39813600/) 9. 9. [Cretu AM, et al. Emerging peptide and neuroendocrine strategies for TRT-induced reproductive suppression and functional male hypogonadism: a narrative review. Front Reprod Health. 2026 (opens in a new tab)](https://pubmed.ncbi.nlm.nih.gov/42666625/) 10. 10. [Lee JH, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst. 1996 (opens in a new tab)](https://pubmed.ncbi.nlm.nih.gov/8944003/) 11. 11. [Muir AI, et al. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem. 2001 (opens in a new tab)](https://pubmed.ncbi.nlm.nih.gov/11387329/) 12. 12. [George JT, et al. Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes. Neuroendocrinology. 2010 (opens in a new tab)](https://pubmed.ncbi.nlm.nih.gov/20628262/) 13. 13. [George JT, et al. Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: kisspeptin-10 stimulates serum testosterone and LH secretion in men with type 2 diabetes and mild biochemical hypogonadism. Clin Endocrinol (Oxf). 2013 (opens in a new tab)](https://pubmed.ncbi.nlm.nih.gov/23153270/) 14. 14. [Jayasena CN, et al. Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. J Clin Invest. 2014 (opens in a new tab)](https://pubmed.ncbi.nlm.nih.gov/25036713/) 15. 15. [Thurston L, et al. Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2022 (opens in a new tab)](https://pubmed.ncbi.nlm.nih.gov/36287566/) 16. 16. [Mills EG, et al. Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2023 (opens in a new tab)](https://pubmed.ncbi.nlm.nih.gov/36735255/) 17. 17. [NCPA. FDA grants enforcement discretion for compounding six peptides. October 29, 2026 (opens in a new tab)](https://ncpa.org/newsroom/qam/2026/10/29/fda-grants-enforcement-discretion-compounding-six-peptides) 18. 18. [FDA. Certain bulk drug substances for use in compounding that may present significant safety risks (current as of April 22, 2026) (opens in a new tab)](https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks) 19. 19. [World Anti-Doping Agency. 2026 Prohibited List (S2.2.1 testosterone-stimulating peptides in males) (opens in a new tab)](https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf) Written by the Vitals Vault editorial team, medically reviewed by Robert Lufkin, MD, and updated October 29, 2026. This is general education, not medical advice. None of these peptides is FDA-approved to diagnose, treat, cure or prevent any disease, and compounded medicines are not FDA-reviewed for safety, effectiveness or quality. Talk to a licensed clinician before starting any treatment. --- Canonical HTML: https://www.vitalsvault.com/peptides/kisspeptin-10 - [llms.txt](https://www.vitalsvault.com/llms.txt) - [sitemap.xml](https://www.vitalsvault.com/sitemap.xml) - [Developer portal](https://www.vitalsvault.com/developers)